Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
International Archives of Allergy and Immunology
|
April 22, 2010
Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus
Laetitia Bussières, Véronique Bordas-Le Floch, Ingrid Bulder, et al.
Cancer Gene Therapy
|
July 2, 2003
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients
Anand G Menon, Peter J K Kuppen, Sjoerd H van der Burg, et al.
Allergy
|
November 28, 2019
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
Erika Jensen-Jarolim, Martin F Bachmann, Sergio Bonini, et al.
Clinical Immunology (Orlando, Fla.)
|
May 12, 2024
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease
Cheïma Boudjeniba, Perrine Soret, Diana Trutschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2005
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells
Nicolas van Baren, Marie-Claude Bonnet, Brigitte Dréno, et al.
Annals of the Rheumatic Diseases
|
December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
Baptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Nature Communications
|
June 11, 2021
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome
Perrine Soret, Christelle Le Dantec, Emiko Desvaux, et al.
Annals of the Rheumatic Diseases
|
June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
Nature Medicine
|
September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine
|
August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
International Archives of Allergy and Immunology
|
April 22, 2010
Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus
Laetitia Bussières, Véronique Bordas-Le Floch, Ingrid Bulder, et al.
Cancer Gene Therapy
|
July 2, 2003
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients
Anand G Menon, Peter J K Kuppen, Sjoerd H van der Burg, et al.
Allergy
|
November 28, 2019
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
Erika Jensen-Jarolim, Martin F Bachmann, Sergio Bonini, et al.
Clinical Immunology (Orlando, Fla.)
|
May 12, 2024
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease
Cheïma Boudjeniba, Perrine Soret, Diana Trutschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2005
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells
Nicolas van Baren, Marie-Claude Bonnet, Brigitte Dréno, et al.
Annals of the Rheumatic Diseases
|
December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
Baptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Nature Communications
|
June 11, 2021
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome
Perrine Soret, Christelle Le Dantec, Emiko Desvaux, et al.
Annals of the Rheumatic Diseases
|
June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
Nature Medicine
|
September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine
|
August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Page
of 12